open
Choose your language
Janssen Initiatives
Janssen & Multiple Myeloma
Janssen’s goal is to fundamentally alter the way cancer is understood, diagnosed and managed. We are committed to finding innovative ways to fight cancer, including for multiple myeloma, and our primary efforts focus on treatment and prevention solutions.
We are driven by our commitment to patients, working side-by-side with healthcare stakeholders, to offer solutions based on trust and transparency. Below are a number of Janssen initiatives that you may find interesting or helpful.
Time Keeper [placeholder content for OpCos to adapt]
Waiting is something that all of us spend time doing at one stage or another. But with a diagnosis like multiple myeloma, waiting can become a huge part of your life and time becomes even more precious. We’ve created the Time Keeper app to help you make the most of your time.
Based on neuroscience and driven by patient insights, Timekeeper is a free app on iPhone and Apple Watch. New impressions take longer for the brain to process than routine ones – making time feel elongated; Time Keeper has been developed to help you try out new activities, and make time stretch so the good moments feel longer.
Stay tuned for further information when we launch during Blood Cancer Awareness Month in September!
Finding the Cure: Exploring the potential of MRD as a novel endpoint
Measurable or minimal residual disease (MRD) refers to the small number of myeloma cells that may remain in your bone marrow following treatment; it plays an important role in monitoring remission status.
In the MRD document, leading physicians, together with patients and patient advocates, explore the potential of MRD as a new study endpoint to measure functional cure, sharing their perspectives on the important role it could play in the management and treatment of multiple myeloma. Click here to watch the documentary now.
المراجع
[1]
National Multiple Sclerosis Society. Types of MS. Available at:https://www.nationalmssociety.org/What-is-MS/Types-of-MS
